Kevin Riley, industry leader with global experience in technology commercialization, joins as presidentCarolyn Magill steps down as CEO; Jeremy Rassen,…
As the stage is set for another year of groundbreaking research and transformative treatment advancements, several companies are seizing the…
FREMONT, Calif., Sept. 12, 2024 /PRNewswire/ -- The 34th Medical Informatics Europe Conference was held in Athens, Greece August 25-29, 2024.…
Company Leverages Causal Machine Learning to Overcome Key Challenges in Developing New Cancer Treatments BOSTON, Sept. 12, 2024 /PRNewswire/ --…
Research presented will include the applications of new diagnostic tools and machine learning multimodal signatures in clinical trials BOSTON and…
MIAMI, FL / ACCESSWIRE / September 12, 2024 / Sema Slim™, the premier online destination for effective telehealth services in…
Phase 2 data demonstrated positive immune responses to A and B strains, with acceptable safety and reactogenicity profile, meeting all…
CARY, NC / ACCESSWIRE / September 12, 2024 / Yunu, a leading provider of clinical trial imaging workflow and data…
Two of the first three patients in the Phase 1 cohort of the Phase 1/2a clinical trial, treated at the…
VYN202 was generally well tolerated with no drug-related adverse eventsPharmacokinetic results demonstrated dose-dependent exposure of VYN202 in blood Pharmacodynamic activity observed…